₹ 2.1 Cr
Volume Transacted
(Dec 12, 2024)
35.9 K
Stocks Traded
(Dec 12, 2024)
Last Updated on: Dec 12, 2024
Granules India Ltd
NSE: GRANULES
ISIN
INE101D01020
Last updated on: Dec 12, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Granules India Ltd
NSE: GRANULES
Share Price
₹ 589.2
4.20 (0.72%)
Last updated on: Dec 12, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
12 Dec 2024 | 589.2 | 556.55 | 592 | 556.55 |
11 Dec 2024 | 585 | 581.25 | 590.35 | 579.25 |
10 Dec 2024 | 583.15 | 579.95 | 584.5 | 575.9 |
09 Dec 2024 | 579.9 | 574.95 | 582.05 | 569.25 |
06 Dec 2024 | 576.05 | 568 | 578.35 | 562 |
05 Dec 2024 | 567.2 | 547.65 | 574.25 | 540.7 |
04 Dec 2024 | 542.5 | 535.2 | 545.1 | 527.05 |
03 Dec 2024 | 534.45 | 597.5 | 627.45 | 528.7 |
02 Dec 2024 | 594.65 | 580.6 | 598 | 580.6 |
29 Nov 2024 | 586.85 | 584.25 | 591.25 | 579.15 |
Date | Price (₹) |
---|---|
12 Dec 2024 | 589.2 |
11 Dec 2024 | 585 |
10 Dec 2024 | 583.15 |
09 Dec 2024 | 579.9 |
06 Dec 2024 | 576.05 |
05 Dec 2024 | 567.2 |
04 Dec 2024 | 542.5 |
03 Dec 2024 | 534.45 |
02 Dec 2024 | 594.65 |
29 Nov 2024 | 586.85 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Last updated time: 12 Dec 9.00 AM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Granules India Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Granules India Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Granules India Ltd gains for fifth session
Granules India Ltd is up for a fifth straight session in a row. The stock is quoting at Rs...
10 Dec 2024 13:00
Granules India Ltd leads losers in 'A' group
C.E. Info Systems Ltd, Zen Technologies Ltd, Deepak Nitrite Ltd and Avalon Technologies Lt...
03 Dec 2024 15:00
Granules India drops after USFDA's 'OAI' status to Gagillapur unit
The United States Food and Drug Administration (USFDA) has further classified the inspecti...
03 Dec 2024 15:25
Granules India Ltd gains for third straight session
Granules India Ltd gained for a third straight session today. The stock is quoting at Rs 5...
02 Dec 2024 13:05
Granules India receives SBTi validation and approval for its net-zero goals
Granules India has received validation and approval from the Science Based Targets initiat...
27 Nov 2024 16:11
Granules India Andhra Pradesh facility gets EIR from USFDA
This US drug regulator conducted an inspection from 8 April to 12 April 2024. Now, the ins...
08 Nov 2024 13:26
Unlimited trading starting at just Rs. 249*